{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:13:39Z","timestamp":1793308419645,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017556","name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.modpat.2026.100965","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:23:43Z","timestamp":1769127823000},"page":"100965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pulmonary Solid and Granular Adenocarcinomas Expressing HepPar1\/CPS1: Highly Aggressive Tumors Exhibiting Mitochondrial Adaptation to STK11 Mutations Rather Than Hepatoid Differentiation"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4754-1344","authenticated-orcid":false,"given":"Christopher A.","family":"Febres-Aldana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad M.","family":"Vanderbilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maelle","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya V.","family":"Seshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Frosina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim A.","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Bodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brie","family":"Kezlarian-Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ladanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Rudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina K.","family":"Baine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5801-3144","authenticated-orcid":false,"given":"Natasha","family":"Rekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2026.100965_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/1097-0142(19860701)58:1<119::AID-CNCR2820580121>3.0.CO;2-U","article-title":"Hepatoid adenocarcinomas of the stomach. An analysis of seven cases","volume":"58","author":"Ishikura","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.modpat.2026.100965_bib2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4065\/72.12.1154","article-title":"Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma)","volume":"72","author":"Roberts","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.modpat.2026.100965_bib3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.5858\/arpa.2017-0485-RS","article-title":"Hepatoid carcinoma of the ovary: clinical, histopathologic, and immunophenotypic features","volume":"143","author":"Acosta","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.modpat.2026.100965_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.humpath.2021.02.003","article-title":"Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers","volume":"115","author":"He","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/01.pas.0000213370.79300.e1","article-title":"Hepatoid carcinoma of the pancreas: a case report and literature review of a heterogeneous group of tumors","volume":"31","author":"Hameed","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.humpath.2022.06.011","article-title":"Hepatoid tumors of the gastrointestinal\/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles","volume":"132","author":"Mattiolo","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00428-003-0772-8","article-title":"Hepatoid adenocarcinoma of the urinary bladder","volume":"442","author":"Lopez-Beltran","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.modpat.2026.100965_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01600112","article-title":"Hepatoid adenocarcinoma: a distinctive histological subtype of alpha-fetoprotein-producing lung carcinoma","volume":"417","author":"Ishikura","year":"1990","journal-title":"Virchows Arch A"},{"key":"10.1016\/j.modpat.2026.100965_bib9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/modpathol.2013.170","article-title":"Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature","volume":"27","author":"Haninger","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3892\/ol.2016.4559","article-title":"Hepatoid adenocarcinoma of the lung without production of \u03b1-fetoprotein: a case report and review of the literature","volume":"12","author":"Sun","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.modpat.2026.100965_bib11","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3390\/jcm12041411","article-title":"Hepatoid adenocarcinoma of the lung: a review of the most updated literature and a presentation of three cases","volume":"12","author":"Bonis","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.modpat.2026.100965_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/labinvest.3700699","article-title":"The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1","volume":"88","author":"Butler","year":"2008","journal-title":"Lab. Invest"},{"key":"10.1016\/j.modpat.2026.100965_bib13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.5858\/arpa.2013-0249-OA","article-title":"HepPar-1 and arginase-1 immunohistochemistry in adenocarcinoma of the small intestine and ampullary region","volume":"139","author":"Lagana","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.modpat.2026.100965_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.MP.0000052103.13730.20","article-title":"Hep Par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections","volume":"16","author":"Fan","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1309\/8L872RPHEJRKF5JJ","article-title":"Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma","volume":"119","author":"Kakar","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00125480-200301000-00004","article-title":"The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: a review","volume":"10","author":"Lamps","year":"2003","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.humpath.2016.04.016","article-title":"Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma","volume":"55","author":"Giedl","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1309\/KC09YTF2M4DLUYQ6","article-title":"Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples","volume":"122","author":"Lugli","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib19","article-title":"Role of CPS1 in cell growth, metabolism, and prognosis in LKB1-inactivated lung adenocarcinoma","volume":"109","author":"\u00c7elikta\u015f","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.modpat.2026.100965_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1309\/AJCP4MXTNQRVOE2T","article-title":"HepPar-1 expression in primary lung adenocarcinoma","volume":"140","author":"Yousem","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.100965_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/his.15517","article-title":"Dynamic nature of hepatic differentiation in lung adenocarcinoma","volume":"87","author":"Takemura","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2026.100965_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature22359","article-title":"CPS1 maintains pyrimidine pools and DNA synthesis in KRAS\/LKB1-mutant lung cancer cells","volume":"546","author":"Kim","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.100965_bib23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41568-018-0054-z","article-title":"Rewiring urea cycle metabolism in cancer to support anabolism","volume":"18","author":"Keshet","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.modpat.2026.100965_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","article-title":"Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review","volume":"9","author":"Fedchenko","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.modpat.2026.100965_bib26","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.modpat.2026.100965_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jmoldx.2020.11.009","article-title":"Rapid EGFR mutation detection using the idylla platform: single-institution experience of 1200 cases analyzed by an in-house developed pipeline and comparison with concurrent next-generation sequencing results","volume":"23","author":"Momeni-Boroujeni","year":"2021","journal-title":"J Mol Diagn"},{"issue":"21","key":"10.1016\/j.modpat.2026.100965_bib28","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1158\/1078-0432.CCR-22-1115","article-title":"Rb tumor suppressor in small cell lung cancer: combined genomic and IHC analysis with a description of a distinct Rb-proficient subset","volume":"28","author":"Aldana","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.100965_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.modpat.2026.100965_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10769","article-title":"Mitochondrial DNA copy number variation across human cancers","volume":"5","author":"Reznik","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.modpat.2026.100965_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mito.2014.10.005","article-title":"Tissue-specific mtDNA abundance from exome data and its correlation with mitochondrial transcription, mass and respiratory activity","volume":"20","author":"D\u2019Erchia","year":"2015","journal-title":"Mitochondrion"},{"key":"10.1016\/j.modpat.2026.100965_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.otorri.2010.08.001","article-title":"Utilidad del anticuerpo antimitocondrial 113-1 en el diagn\u00f3stico y categorizaci\u00f3n de los tumores de gl\u00e1ndula salival con diferenciaci\u00f3n oncoc\u00edtica","volume":"62","author":"Vera-Sempere","year":"2011","journal-title":"Acta Otorrinolaringol Esp"},{"key":"10.1016\/j.modpat.2026.100965_bib33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00428-005-0137-6","article-title":"Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy","volume":"448","author":"Ambrosini-Spaltro","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.modpat.2026.100965_bib34","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/00000478-199708000-00006","article-title":"Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors","volume":"21","author":"Tickoo","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-018-9555-2","article-title":"The role of immunohistochemistry and molecular analysis of succinate dehydrogenase in the diagnosis of endocrine and non-endocrine tumors and related syndromes","volume":"30","author":"Oudijk","year":"2019","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.100965_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.modpat.2026.100965_bib38","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.21037\/tlcr-20-760","article-title":"Emerging and multifaceted role of neutrophils in lung cancer","volume":"10","author":"Aloe","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.modpat.2026.100965_bib39","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/00000478-200110000-00011","article-title":"Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas","volume":"25","author":"Borscheri","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib40","doi-asserted-by":"crossref","first-page":"75425","DOI":"10.18632\/oncotarget.12251","article-title":"Targeting SALL4 by entinostat in lung cancer","volume":"7","author":"Yong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.modpat.2026.100965_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1309\/CADCVWHR2QF6JMVN","article-title":"Cytoplasmic immunoreactivity of thyroid transcription factor-1 (Clone 8G7G3\/1) in hepatocytes: true positivity or cross-reaction?","volume":"128","author":"Gu","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib42","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1309\/EBCB6H54K1N2P9QL","article-title":"The binding of thyroid transcription factor-1 and hepatocyte paraffin 1 to mitochondrial proteins in hepatocytes: a molecular and immunoelectron microscopic study","volume":"125","author":"Pang","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108784","article-title":"Whole-genome characterization of lung adenocarcinomas lacking the RTK\/RAS\/RAF pathway","volume":"34","author":"Carrot-Zhang","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.modpat.2026.100965_bib44","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1158\/2159-8290.CD-16-1337","article-title":"Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies","volume":"7","author":"Jordan","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.modpat.2026.100965_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.108058","article-title":"STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status","volume":"199","author":"De Giglio","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.modpat.2026.100965_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humpath.2016.04.008","article-title":"Arginase-1 is frequently positive in hepatoid adenocarcinomas","volume":"55","author":"Chandan","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib47","article-title":"Gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: a study with emphasis on clear cells and clinicopathologic spectrum","volume":"215","author":"Kwon","year":"2019","journal-title":"Pathol Res Pr"},{"key":"10.1016\/j.modpat.2026.100965_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216104","article-title":"Hepatoid adenocarcinoma-clinicopathological features and molecular characteristics","volume":"559","author":"Li","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.modpat.2026.100965_bib49","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/JTO.0000000000000173","article-title":"LKB1 loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT","volume":"9","author":"Kaufman","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.modpat.2026.100965_bib50","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2159-8290.CD-14-1236","article-title":"Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities","volume":"5","author":"Skoulidis","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.modpat.2026.100965_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2012.12.008","article-title":"LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin","volume":"23","author":"Shackelford","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2026.100965_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1448219","article-title":"Primary hepatoid adenocarcinoma of the lung with extremely elevated serum AFP: a case report and literature review","volume":"14","author":"Cai","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.modpat.2026.100965_bib53","article-title":"Hepatoid adenocarcinoma of the lung responsive to frontline combination chemotherapy with immunotherapy: case report","volume":"2","author":"Lagos","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.modpat.2026.100965_bib54","article-title":"Primary pulmonary hepatoid adenocarcinoma: a case report and review of the literature","volume":"98","author":"Yang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.modpat.2026.100965_bib55","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/dc.24195","article-title":"Hepatoid adenocarcinoma of the lung","volume":"47","author":"Kuan","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.modpat.2026.100965_bib56","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1007\/s12029-011-9318-5","article-title":"Hepatoid adenocarcinoma of the lung: a case report and literature review","volume":"43","author":"Mokrim","year":"2012","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.modpat.2026.100965_bib57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00428-024-03816-6","article-title":"Expression patterns of HNF4\u03b1, TTF-1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features","volume":"486","author":"Kawai","year":"2025","journal-title":"Virchows Arch"},{"key":"10.1016\/j.modpat.2026.100965_bib58","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2559.2011.03764.x","article-title":"The predominant expression of hepatocyte nuclear factor 4\u03b1 (HNF4\u03b1) in thyroid transcription factor-1 (TTF-1)-negative pulmonary adenocarcinoma","volume":"58","author":"Kunii","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2026.100965_bib59","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ccell.2024.05.002","article-title":"Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2026.100965_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2025.104210","article-title":"Clinicopathologic, cellular, and molecular analyses of pulmonary neuroendocrine carcinoma with high expression of hepatocyte nuclear factor 4 alpha","volume":"105","author":"Asayama","year":"2025","journal-title":"Lab Invest"},{"key":"10.1016\/j.modpat.2026.100965_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110872","article-title":"LKB1 and cancer: the dual role of metabolic regulation","volume":"132","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.modpat.2026.100965_bib62","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.modpat.2026.100965_bib63","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","article-title":"Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non\u2013small cell carcinoma\u2013like subsets","volume":"22","author":"Rekhtman","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.100965_bib64","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-017-2148-5","article-title":"SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg\/CK7pos\/HepPar-1pos immunophenotype","volume":"471","author":"Agaimy","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.modpat.2026.100965_bib65","article-title":"A case report of pulmonary hepatoid adenocarcinoma: promoting standardized diagnosis and treatment of the rare disease","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.modpat.2026.100965_bib66","article-title":"Primary hepatoid adenocarcinoma of the lung in patient with silicosis: a case report and literature review","volume":"14","author":"Huang","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.modpat.2026.100965_bib67","article-title":"Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: report of four cases","volume":"229","author":"Sun","year":"2022","journal-title":"Pathol Res Pr"},{"key":"10.1016\/j.modpat.2026.100965_bib68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.humpath.2021.09.006","article-title":"Genomic characterization of hepatoid tumors: context matters","volume":"118","author":"Lawlor","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.100965_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00307","article-title":"Harnessing clinical sequencing data for survival stratification of patients with metastatic lung Adenocarcinomas","volume":"3","author":"Shen","year":"2019","journal-title":"JCO Precis. Oncol"},{"key":"10.1016\/j.modpat.2026.100965_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2020.07.010","article-title":"Histopathological subtyping is a prognostic factor in stage IV lung adenocarcinoma","volume":"147","author":"Cruz","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.modpat.2026.100965_bib71","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41586-019-1715-0","article-title":"In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer","volume":"575","author":"Momcilovic","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.100965_bib72","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chembiol.2020.01.009","article-title":"Small molecule inhibition of CPS1 activity through an allosteric pocket","volume":"27","author":"Yao","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.modpat.2026.100965_bib73","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/cac2.12402","article-title":"Impact of small molecule-mediated inhibition of ammonia detoxification on lung malignancies and liver metabolism","volume":"43","author":"Makris","year":"2023","journal-title":"Cancer Commun"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:34:31Z","timestamp":1782128071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0893395226000086"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.100965","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Solid and Granular Adenocarcinomas Expressing HepPar1\/CPS1: Highly Aggressive Tumors Exhibiting Mitochondrial Adaptation to STK11 Mutations Rather Than Hepatoid Differentiation","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.100965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"100965"}}